Stay updated on COTEZO IMblaze370 Clinical Trial
Sign up to get notified when there's something new on the COTEZO IMblaze370 Clinical Trial page.

Latest updates to the COTEZO IMblaze370 Clinical Trial page
- CheckyesterdayChange DetectedThe page has removed a significant clinical trial reference regarding the use of atezolizumab and cobimetinib in metastatic colorectal cancer, which may impact the information available to readers about treatment options.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and inclusion/exclusion criteria for a clinical trial on colorectal cancer, while adding a new revision number and the term 'Colorectal Cancer'.SummaryDifference18%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.8%
Stay in the know with updates to COTEZO IMblaze370 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the COTEZO IMblaze370 Clinical Trial page.